Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.
Covista Inc., formerly Adtalem Global Education Inc. (ATGE), reports developments tied to its healthcare education business and completed corporate rebranding. News about the company centers on enrollment trends, earnings results, strategic planning, and the role of its institutions in preparing healthcare professionals for the U.S. workforce.
Recurring updates cover Chamberlain University, Walden University, Ross University School of Medicine, academic program expansion, technology-enabled curriculum initiatives, healthcare workforce research, and leadership changes at operating institutions. Corporate news also documents the transition from Adtalem to Covista and the company’s move from ATGE to the CVSA ticker on the New York Stock Exchange.
Adtalem Global Education Inc. (NYSE: ATGE) reported strong fiscal third quarter 2024 results with revenue up 11.8% YoY, total enrollment up 7.8% YoY, and adjusted EPS growth of 32.7% YoY. The company's strategic focus on Growth with Purpose led to accelerated enrollment growth, enhanced profitability, and robust financial performance. Adtalem's subsidiaries achieved high residency attainment rates, expanded nursing education programs, and increased student enrollment. The company raised its fiscal year 2024 revenue guidance to $1,560 million to $1,580 million and adjusted EPS to $4.80 to $5.00.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.